Pharmaceutical companies are increasingly embracing data analytics and artificial intelligence (AI) to enhance clinical trial monitoring, compliance, and medical coding accuracy. Experts from Sage Therapeutics and Daiichi Sankyo shared strategies for leveraging internal data resources, aligning with commercial teams, and overcoming resource constraints at a recent industry congress. Simultaneously, startups like Arintra raised $21 million to develop AI-powered platforms that automate medical coding and optimize reimbursement, demonstrating growing industry investment in AI tools to enhance operational efficiency and revenue cycle management.